Mobile Menu

Search Results

Search results for: drug targets

Potential drug targets for paediatric germ cell tumours

Researchers have performed a comprehensive genetic analysis and identified potential drug targets for paediatric germ cell tumours (GCTs). Germ cell […]

The Genetics Of Alzheimer’s: Uncovering new Mechanisms and Drug Targets

An understanding of the environmental and genetic risk of Alzheimer’s Disease is vital for the production of more effective therapies. […]

‘Druggable’ pockets in SARS-CoV-2 protein offer new therapeutic targets

The COVID-19 pandemic was controlled due to the rapid development of new vaccines and anti-viral drugs. However, the emergence of […]

UCL finds mutations in SARS-CoV-2 that offer insights into drug and vaccine targets

A study conducted by a team at UCL identified potential drug and vaccine targets for SARS-CoV-2. The results of the […]

Proteogenomics in Drug Discovery: Appreciating the Big Picture

The use of genomics in drug discovery has been heralded as a revolutionary tool. With most drugs ultimately failing at […]

AI in Drug Discovery 2024: Where are we now?

Back in 2020, we covered an industry analysis of the role of Artificial Intelligence in Drug Discovery. The report covered […]

Genomics in Drug Discovery ONLINE

On average, it takes 10.5 years for a Phase I drug to progress to regulatory approval and only ~8% of […]

The State Of: Genomics in Drug Discovery

Drug discovery can be a long and gruelling process, but this effort is vital to advance human health. As is […]

Exemplar uses of multi-omics in drug discovery

The drug discovery process can be long and gruelling, but when backed by genetic evidence, drugs are twice as likely […]

Genomics in Drug Discovery ONLINE

Only 10% of new molecular entities that are in early clinical trials ever make it to approval. However, those with […]